sb 203580 has been researched along with nad in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (nad) | Trials (nad) | Recent Studies (post-2010) (nad) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 30,121 | 88 | 5,663 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Calabresi, P; Darnowski, JW; Freeman, SM; Whartenby, KA | 1 |
1 other study(ies) available for sb 203580 and nad
Article | Year |
---|---|
A role for MAP kinase in the antitumor activity of a nucleoside analog.
Topics: Antiviral Agents; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Colony-Forming Units Assay; Cytidine Deaminase; DNA-Directed DNA Polymerase; DNA, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Ganciclovir; Herpesvirus 1, Human; Humans; Imidazoles; Mitogen-Activated Protein Kinases; NAD; Nucleic Acid Synthesis Inhibitors; Poly(ADP-ribose) Polymerases; Pyridines; Thymidine Kinase; Tumor Cells, Cultured | 2002 |